Search results for: 'supplements for obesity'

19 Aug 2025  |  Global  |  Market Research

Salt and Fat Alternative Ingredients Market, Global, 2025–2031

Salt Alternatives are Experiencing Transformational Growth Driven by Increasing Consumer Awareness and Regulatory Intervention

Infographics

×

Growing concerns about cardiovascular disease, obesity, hypertension, and other lifestyle-related illnesses have been linked to the high consumption of processed and ultra-processed foods (UPF) globally, which often contain excessive salt and fat to enhance flavor and prolong shelf life.Consumer attitudes toward salt and fat are rapidly evolving, s...

Cardiovascular diseases (CVDs) remain the leading cause of global morbidity and mortality, with reported cases having doubled since 1990. Today, CVDs account for 1 in 3 deaths worldwide, representing 32% of total global mortality, with heart attacks and ischemic strokes responsible for approximately 85% of these outcomes. The rising burden is stron...

04 Oct 2021  |  Europe  |  Market Research

Global Probiotic Ingredients in Human Nutrition Growth Opportunities

Future Growth Potential Due to Consumer Cognizance and New Product Development

Infographics

×

This research service analyzes the global probiotic ingredients market, covering North America, Europe, Asia-Pacific (APAC), and Rest of World. Global and regional trends are detailed in the study, and it focuses on probiotic ingredients used across end applications, such as functional food & beverages, dietary supplements, pharmaceutical, others (...

17 Oct 2019  |  Global  |  Market Research

Global Analytical Instrumentation Market in Pharmaceuticals, Biopharmaceuticals, and Nutraceuticals, Forecast to 2025

Growth of Biosimilars and Nutraceuticals will Drive Growth

Infographics

×

The global pharmaceuticals, biopharmaceuticals, and nutraceuticals market includes market revenues of analytical instrumentation applied in the 3 segments. Analytical instruments are applied in research, development, manufacturing, quality control, and distribution of drugs. Some key applications include (and are not limited to) drug discovery and ...

Worldwide cancer incidence is expected to exceed 35 million new cases by 2050, a 77% rise from the 20 million cases in 2022. Alcohol intake, tobacco usage, obesity, and air pollution are the main causes of this increase. Cancer studies today emphasize cell and gene therapy, antibody-drug conjugates (ADCs), checkpoint inhibitors, and multi-specific...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping therapeutics, diagnostics, and drug delivery across infectious diseases, oncology, rare genetic disorders, autoimmune conditions, cardiovascular disease, pulmonary fibrosis, neurodegeneratio...

The Transformational Health team at Frost & Sullivan provides critical insights into the US and EU upstream bioprocessing market, highlighting drug demand trends, installed capacity developments, market revenue forecast by various segments, competitive landscape, and key growth opportunities that currently exist or are set to develop during the for...

This edition of Trend Opportunity Profiles features trends in health, wellness, and nutrition advancements focused on the integration of intelligent tools, personalization, and consumer preferences. The use of advanced sensor technologies, intelligent nutrition assistants, and digital wellness platforms (such as AR, VR, and haptics) to create an im...

The human microbiome is made of several microorganisms that reside within and outside the body. These comprise complex and diverse bacteria, archaea, fungi, viruses, and protozoa. They form signature colonies unique to an individual or body part and help maintain general health and wellness. Any disruptions to the naturally occurring healthy microb...